"With 19 new psychiatric drugs, 19 new forms of previously available drugs, and new medical agents, this third edition of the Clinical Manual of Psychopharmacology in the Medically Ill has been updated to account for both medical and psychiatric drugs that have become available since the 2017 publication of the second edition, as well as recent relevant randomized controlled trials, systematic reviews, and meta-analyses. Every chapter has been reviewed and revised by experts to guarantee the most up-to-date information on key differential diagnostic considerations, drug-drug interactions, disease-specific side effects of psychiatric drugs, and more for 15 categories of medical disorders, including cardiovascular disorders, oncology, obstetrics and gynecology, and substance use disorders. Deftly examining the intersection of psychiatric and medical illness, this new volume will prove an indispensable resource for mental health practitioners, as well as primary care physicians and internists, seeking to more safely and effectively work with patients with these comorbidities"--